Gemphire Announces Top-Line Data from Familial Partial Lipodystrophy (FPLD) Phase 2a Proof-of-Concept NAFLD/NASH Clinical Trial June 26, 2019 - NASDAQ Companies 0 » View More News for June 26, 2019